Justine Lin

Associate

台北 + 886.2.7712.3205

Justine Lin's practice focuses on general corporate issues, mergers and acquisitions, and foreign investment control. She has worked on matters involving diverse industries, including energy, media, and technology.

Prior to joining Jones Day, Justine assisted in researching new tobacco control policies. She has experience in regulatory matters concerning new tobacco products such as e-cigarettes and heated tobacco products. She also has experience in the revocation of Withhold Release Orders (WROs) issued by U.S. Customs and Border Protection (CBP) and in the development of corrective action plans (CAPs) addressing forced labor issues in the distant-water fishing industry.

担当案件

  • Delta Electronics acquires ACT Genomics from Prenetics Global Limited and other shareholdersJones Day advised Delta Electronics, Inc., a global leader in power management and smart green solutions, in its $71.78 million acquisition of ACT Genomics Holdings Company Limited from Prenetics Global Limited, a leading consumer health sciences company, and other shareholders.
  • Peabody acquires Tier 1 Australian metallurgical coal assets from Anglo AmericanJones Day is advising Peabody in the pending acquisition of significant Tier 1 Australian Metallurgical coal assets from Anglo American plc for a cash consideration of up to US$3.775 billion.